You are here

Love Pharma Inc.

Love Pharma Inc.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
LUV
CSE Index: 
Currency: 

Love Pharma Inc., is a specialized health and wellness company offering pharmaceutical and therapeutic products with proven technologies for which it has the exclusive rights to produce, package and sell thoughout  Europe, North America and the United Kingdom. Many of the products are market-ready, with proven history of significant sales. The Company is focused on the global sexual wellness and enhancement market. 

You are here

Love Pharma Inc. (LUV)

SEDAR Information

Company Info

Address
1780 - 355 Burrard Street
Vancouver, BC V6C 2G8
Canada
Phone
1-(604)343-2977
Email
investors@love-pharma.com
Listing date
Friday, October 29, 2004
Transfer Agent
Odyssey Trust Company
Investor Relations
General Investor Inquiries
Email
investors@love-pharma.com
Auditor
Baker Tilly

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
314,919,945
Reserved for Issuance: 
73,626,130

Company Officers

Zach Stadnyk, President/CEO
Joshua Maurice, Chief Operating Officer
Tatiana Kovaleva, CFO
Douglas Taylor, Director
Mark Tommasi, Director

Bulletins

29/09/2021

2021-0939 – Fundamental Change – Glenbriar Technologies Inc./Love Pharma Inc.

Le 29 septembre/September 2021

Love Pharma Inc., the issuer resulting from a Fundamental Change of Glenbriar Technologies Inc. (GTI.X), has been approved for listing.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2022-01-25-Jamaica-Stock-Exchange-Conference_Website.png

17th Regional Investments & Capital Markets Conference 2022

Tuesday, January 25, 2022 to Thursday, January 27, 2022
VRIC_1200x675.jpg

Vancouver Resource Investment Conference (VRIC)

Tuesday, May 17, 2022 - 8:30am to Wednesday, May 18, 2022 - 5:30pm